Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-106
Closed -$19.7K 318
2025
Q4
$19.7K Hold
106
0.01% 112
2025
Q3
$21.4K Hold
106
0.01% 106
2025
Q2
$23.2K Buy
+106
New +$23.9K 0.01% 96
2017
Q2
Sell
-2,788
Closed -$206K 168
2017
Q1
$206K Buy
+2,788
New +$199K 0.04% 112
2016
Q4
Sell
-3,807
Closed -$256K 163
2016
Q3
$256K Buy
3,807
+647
+20% +$43.3K 0.07% 115
2016
Q2
$216K Buy
3,160
+918
+41% +$58.9K 0.07% 112
2016
Q1
$136K Buy
+2,242
New +$126K 0.03% 125
2015
Q1
Sell
-1,355
Closed -$78K 179
2014
Q4
$78K Buy
+1,355
New +$74.3K 0.02% 146

Other funds holding MRSH

Howard Hughes Medical Institute's MRSH Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Marsh (MRSH) in Q1 2026, closing a stake of 106 shares — an estimated $19.7K sold.

Howard Hughes Medical Institute first reported a position in MRSH in Q4 2014 and held it in 8 quarters. The position peaked at $256K in Q3 2016. 1,537 funds tracked by Wall St. Rank hold MRSH as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Marsh position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 106 Marsh shares in Q1 2026, an estimated $19.7K.
  • Howard Hughes Medical Institute first reported a position in Marsh in Q4 2014 and held it in 8 quarters.
  • Howard Hughes Medical Institute's Marsh position peaked at $256K in Q3 2016.
  • 1,537 funds tracked by Wall St. Rank held Marsh as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.